Table 1.
The percent positive of the triage tests/methods among HPV DNA positives by specimen collection method (clinician or self) and test (careHPV™ or Hybrid Capture 2 [HC2]), overall and by age group
| Clinician collection | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| careHPV | HC2 | |||||||||||
| careHPV+ | HC2+ | |||||||||||
| HPV16/18/45 | Colpo | HPV16/18/45 | ||||||||||
| n | careHPV (≥10) | DNA1 | E6 | impression | VIA (2nd) | n | HC2 (≥10) | E6 | Colpo Impression | VIA (2nd) | ||
| All | 1065 | 58.3 | 28.4 | 10.5 | 19.9 | 16.4 | 1076 | 62.6 | 10.5 | 20.9 | 17.4 | |
| Age group (years) | ||||||||||||
| <30 | 46 | 58.7 | 30.4 | 2.2 | 37.0 | 30.2 | 47 | 53.2 | 2.1 | 34.0 | 27.3 | |
| 30–39 | 241 | 59.8 | 28.2 | 7.5 | 29.9 | 26.0 | 240 | 65.8 | 7.5 | 32.5 | 28.7 | |
| 40–49 | 401 | 58.4 | 27.2 | 9.2 | 20.2 | 16.3 | 410 | 62.4 | 9.0 | 21.0 | 17.2 | |
| 50+ | 377 | 57.3 | 29.4 | 14.9 | 11.1 | 8.7 | 379 | 61.7 | 15.0 | 11.9 | 9.5 | |
| Self collection | ||||||||||||
| careHPV | HC2 | |||||||||||
| careHPV+ | HC2+ | |||||||||||
| HPV16/18/45 | Colpo | HPV16/18/45 | ||||||||||
| N | careHPV (≥10) | DNA1 | E6 | impression | VIA (2nd) | n | HC2 (≥10) | E6 | Colpo Impression | VIA (2nd) | ||
| All | 1074 | 48.0 | 23.4 | 8.7 | 17.8 | 14.8 | 1329 | 52.1 | 7.9 | 18.0 | 15.1 | |
| Age group (years) | ||||||||||||
| <30 | 51 | 47.1 | 25.5 | 2.0 | 27.5 | 22.5 | 54 | 64.8 | 1.9 | 29.6 | 25.0 | |
| 30–39 | 232 | 45.3 | 23.7 | 6.0 | 28.9 | 25.1 | 315 | 47.9 | 5.4 | 28.6 | 24.6 | |
| 40–49 | 406 | 47.8 | 20.9 | 8.1 | 17.5 | 14.1 | 525 | 51.2 | 7.2 | 17.0 | 14.1 | |
| 50+ | 385 | 50.1 | 25.5 | 11.7 | 10.1 | 8.2 | 435 | 54.7 | 11.3 | 10.1 | 8.5 | |
1
careHPV™ test.
Abbreviations: VIA, visual inspection after acetic acid; rlu/pc, relative light units per positive control (signal strength).